Ekso Bionics to Present at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on September 16, 2020
September 09, 2020 08:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that...
Ekso Bionics® Unveils its Latest Assistive Exoskeleton Innovation for Industrial Use
August 20, 2020 08:30 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Reports Second Quarter 2020 Results
July 30, 2020 16:05 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics® to Report Second Quarter 2020 Financial Results on July 30, 2020
July 23, 2020 08:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it...
Army Distaff Foundation-Knollwood is First Life Plan Community to Adopt Ekso Bionics’ Exoskeleton Device for Rehabilitation Following Successful Trial
July 09, 2020 08:00 ET
|
Ekso Bionics Holdings, Inc.
WASHINGTON and RICHMOND, Calif., July 09, 2020 (GLOBE NEWSWIRE) -- The Army Distaff Foundation (ADF), a non-profit charity in Washington, D.C., which operates Knollwood Military Life Plan ...
Ekso Bionics® Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Acquired Brain Injury Patients
June 25, 2020 08:30 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., June 25, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Announces Closing of $7.89 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
June 10, 2020 13:30 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., June 10, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Announces $7.89 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
June 08, 2020 08:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics® Named “Best Healthcare Robotics Company” in 2020 MedTech Breakthrough Awards Program
June 03, 2020 08:00 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., June 03, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...
Ekso Bionics Announces CFIUS Determination Regarding China Joint Venture
May 20, 2020 16:10 ET
|
Ekso Bionics Holdings, Inc.
RICHMOND, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today...